The COVID-19 pandemic has underscored the need to bring life sciences manufacturing back to the United States, according to one industry insider.
Domestic manufacturing is "a very, very big investment that the tenant has to make in addition to what the landlord is providing," broker Ted Jacobs told CBRE's Spencer Levy on a recent podcast.
"We are seeing a lot of companies due to supply chain issues do a national search to build out a new manufacturing plant. A lot of those transactions happened last year," Jacobs, who is based in San Diego, said. "I would say it slowed down just a little bit at the start of '22, but there's definitely a need to have a better supply chain and have in the United States and control the workforce a bit more as well."
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
